Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
aggression
algorithm
amnestic syndrome
AMPA receptor antibodies
AMPA receptors
amygdala
anti GQ1b IgG antibody
ataxia
ataxia, cerebellar
autoantibodies
autoimmune basal ganglia encephalitis
autoimmune disease
autonomic dysfunction
basal ganglia, lesion of
basal ganglia, lesion, bilateral
behavior, combative
behavioral disorder
behavioral disorder, acute
carcinoma
carcinoma of breast
carcinoma of lung
CAT scan, chest
catatonia
cerebellum
cerebral cortex
children
chorea
choreoathetosis
collapsin response mediator protein 5 IgG
complications
confusion
contactin associated protein like 2 antibodies
cortical ribbon sign
dementia
dementia, reversible
diagnostic criteria
diarrhea
differential diagnosis
DPPX, antibodies, encephalitis
dyskinesia
dyskinesia, facial
dystonia
encephalitis
encephalitis, autoimmune
encephalitis, brainstem
encephalitis, etiology
encephalitis, paraneoplastic
encephalitis, viral
encephalopathy, Hashimoto's
faciobrachial dystonic seizure
false negative
fever
gamma amino butyric acid receptor antibody
gammaglobulin therapy, intravenous
gender
GluD2
glutamic acid decarboxylase, antibody
glycine receptor antibodies
hallucination
hallucination, visual
headache
herpes simplex encephalitis
hippocampus
hippocampus, hyperintense
Hodgkin's disease
Hodgkin's disease, neurologic involvement with
hyperekplexia
hypersomnia
hyponatremia
immunologic disease
immunosuppressive agents
immunotherapy
inappropriate antidiuretic(A.D.H.)hormone
insomnia
insular cortex
intellectual deficit
intellectual deterioration
Jakob-Creutzfeldt disease
leucine rich glioma inactivated 1 antibodies
level of consciousness, decreased
limbic encephalitis
limbic system
malignancy screen
mediastinum, mass of
memory, defect of recent
memory, impairment of
mental status, abnormal
mesial temporal lobe
mimics
misdiagnosis
monoclonal antibodies
Morvan's fibrillary chorea
movement disorder
MRI
MRI, abnormal
MRI, diffusion weighted
MRI, false negative
MRI, FLAIR
MRI, negative
myelitis, transverse, recurrent
myoclonus
negative
neurexin-3 alpha antibodies
neurologic complications of, systemic cancer
neurologic disease, diagnoses of
neuronal cell surface antigen
NMDA antagonists
ophelia syndrome
opsoclonus
opsoclonus-myoclonus syndrome
pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection
personality change
pleocytosis of cerebrospinal fluid
potassium channel antibodies
practice guidelines
precipitating factors
prognosis
psychiatric problems in neurologic disorders
psychosis
Purkinje cell
Purkinje cell surface antibody
rapidly progressing neurologic illness
recurrent
remote effect of cancer on the nervous system
reversible neurologic disorder
review article
rituximab
screening
seizure
serologic testing
serologic testing, false negative
seronegative
sleep pathology and physiology
steroid
steroid responsive encephalopathy
steroid therapy, CNS treatment and complications with
striatal encephalitis
striatum, lesion of
striatum, lesion of, bilateral
symmetric brain lesions
syphilis, neurologic complications with
tau protein
temporal lobe
temporal lobe, lesion
temporal lobe, lesion, bilateral
teratoma
teratoma, ovarian
thymoma
treatment of neurologic disorder
tremor
violent behavior
weight loss
white matter disease
white matter disease, subcortical
workup
Showing articles 650 to 700 of 1195 << Previous Next >>

Intravenous Valproic Acid for Myoclonic Status Epilepticus
Neurol 54:1201, Sheth,R.D. & Gidal,B.E., 2000

Aspirin-Associated Intracerebral Hemorrhage
Neurol 54:2298-2301, Wong,K.S.,et al, 2000

Update on Antiplatelet Therapy for Stroke Prevention
Arch Int Med 160:1579-1582, Sacco,R.L.& Elkind,M.S., 2000

Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel
NEJM 342:1773-1777,1824, Bennett,C.L.,et al, 2000

Intravenous Valproate in Pediatric Epilepsy Patients with Refractory Status Epilepticus
Neurol 54:2188-2189, Uberall,M.A.,et al, 2000

Reduced Prevalence of AD in Users of NSAIDs and H2 Receptor Antagonists
Neurol 54:2066-2071, Anthony,J.C.,et al, 2000

Indications for Early Aspirin Use in Acute Ischemic Stroke
Stroke 31:1240-1249, Chen,Z.,et al, 2000

Occupational Exposure to Methyl Isobutyl Ketone Causes Lasting Impairment in Working Memory
Neurol 54:1853-1855, Grober,E.&Schaumburg,H.H., 2000

Epilepsy in Elderly People
Lancet 355:1441-1446, Stephen,L.J.&Brodie,M.J., 2000

Low Molecular-Weight Heparin Versus Aspirin in Patients With Acute Ischaemic Stroke and Atrial Fibrillation: A Double-Blind Randomised Study
Lancet 355:1205-1210, Berge,E.,et al, 2000

Valproate, Hyperandrogenism, and Polycystic Ovaries
Arch Neurol 57:1064-1068, Isojarvi,J.I.T. & Tapanainen,J.S., 2000

Thienopyridines or Aspirin to Prevent Stroke and Other Serious Vascular Events in patients at High Risk of Vascular Disease?
Stroke 31:1779-1784, Hankey,G.J. et al, 2000

Hypothermia and Thermoregulatory Derangements Induced by Valproic Acid
Neurol 55:150-151, Zachariah,S.B. et al, 2000

Symptomatic Intracranial Atherosclerosis
Neurol 55:490-497, 465, Thijs,V.N. & Albers,G.W., 2000

Neural-Tube Defects
NEJM 341:1509-1519,1485, Botto,L.D.,et al, 1999

Antiepileptic Drug Regimens and Major Congenital Abnormalities in the Offspring
Ann Neurol 46:739-746, Samren,E.B.,et al, 1999

Effect of Vitamin C on Frequency of Reflex Sympathetic Dystrophty in Wrist Fractures:A Randomised Trial
Lancet 354:2025-2028, Zollinger,P.E.,et al, 1999

Treatment of Absence Status with Intravenous Valproate
Neurol 52:889-890, Alehan,F.K.,et al, 1999

Secondary Prevention after Cerebral Ischaemia of Presumed Arterial Origin:Is Aspirin Still the Touchstone?
JNNP 66:557-559, Algra,A.,et al, 1999

Preventing Stroke in Patients with Atrial Fibrillation
JAMA 281:1830-1835, Ezekowitz,M.D.&Levine,J.A., 1999

Antiplatelet Therapy in Acute Cerebral Ischemia
Stroke 30:887-893, Bednar,M.M.&Gross,C.E., 1999

Risk of Primary Intracerebral Haemorrhage Associated with Aspirin and Non-Steroidal Anti-Inflammatory Drugs:Case-Control Study
BMJ 318:759-764, Thrift,A.G.,et al, 1999

High Monounsaturated Fatty Acids Intake Protects Against Age-Related Cognitive Decline
Neurol 52:1563-1569, Solfrizzi,V.,et al, 1999

A New Metabolite Contributing to N-Acetyl Signal in 1H MRS of the Brain in Salla Disease
Neurol 52:1668-1672, Varho,T.,et al, 1999

Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999

Reye's Syndrome in the United States from 1981 Through 1997
NEJM 340:1377-1382,1423, Belay,E.D.,et al, 1999

Sjogren-Larsson Syndrome, Clinical and MRI/MRS Findings in FALDH-Deficient Patients
Neurol 52:1345-1352,1307, Van Domburg,P.H.M.F.,et al, 1999

Intractable Epilepsy
Lancet 353:1238, Shuper,A.,et al, 1999

Factors Associated with Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation, Analysis of 2012 Participants in the SPAF-I-III Clinical Trials
Stroke 30:1223-1229, Hart,R.G.,et al, 1999

A Metaregression Analysis of the Dose-Response Effect of Aspirin on Stroke
Arch Int Med 159:1248-1253, Johnson,E.S.,et al, 1999

Low-Dose and High-Dose Acetylsalicylic Acid for Patients Undergoing Carotid Endarterectomy:A Randomised Controlled Trial
Lancet 353:2179-2184,2172, Taylor,D.W.,et al, 1999

Relation of Consumption of Vitamin E, Vitamin C, and Carotenoids to Risk for Stroke among Men in the United States
Ann Int Med 130:963-970, Ascherio,A.,et al, 1999

Therapeutic Benefit, Aspirin Revisited in Light of the Introduction of Clopidogrel
Stroke 30:1716-1721, Gorelick,P.B.,et al, 1999

Folic Acid for the Prevention of Neural Tube Defects
Pediartrics 104:325-327, Committee on Genetics, 1999

Prospective Study of Aspirin Use and Risk of Stroke in Women
Stroke 30:1764-1771, Iso,H.,et al, 1999

Antiplatelet Treatment Does Not Reduce the Severity of Subsequent Stroke
Neurol 53:825-829, Sivenius,J.,et al, 1999

Dipyridamole Plus Aspirin in Cerebrovascular Disease
Arch Neurol 56:1087-1092, Wilterdink,J.L.&Easton,J.D., 1999

Treatment and Secondary Prevention of Stroke:Evidence, Costs, and Effects on Individuals and Populations
Lancet 354:1457-1463, Hankey,G.J.&Warlow,C.P., 1999

Primary Prevention of Arterial Thromboembolism in Non-Rheumatic Atrial Fibrillation in Primary Care:Randomised Controlled Trial Comparing Two Intensities of Coumarin with Aspirin
BMJ 319:958-964, Hellemons,B.S.P.,et al, 1999

Antithrombotic Therapy to Prevent Stroke in Patients with Atrial Fibrillation:A Meta-Analysis
Ann Int Med 131:492-501,537, Hart,R.G.,et al, 1999

Antiplatelet Therapy:Views from the Experts
Neurol 53:S32-S37, Easton,J.D.,et al, 1999

Frequency of Major Complications of Aspirin,Warfarin,and Intravenous Heparin for Secondary Stroke Prevention,A Population-Based Study
Ann Int Med 130:14-22, Petty,G.W.,et al, 1999

Aspirin and Risk of Hemorrhagic Stroke
JAMA 280:1930-1935,1949, He,J.,et al, 1998

Medically Induced Gingival Hyperplasia
Mayo Clin Proc 73:1196-1199, Meraw,S.J. &Sheridan,P.J., 1998

Aggressive Approach in the Treatment of Acute Lead Encephalopathy with an Extraordinarily High Concentration of Lead
Arch Pediatr Adolesc Med 152:1100-1104, Gordon,R.A.,et al, 1998

Dipsticks and Convulsions
Lancet 352:1824, Koch,H., 1998

Management Issues for Women with Epilepsy,A Review of the Literature
Neurol 51:949-956, Zahn,C.A.,et al, 1998

Analysis of Prenatal and Gestational Care Given to Women with Epilepsy
Neurol 51:1039-1045, Seale,C.G.,et al, 1998

Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998

Stiff-Leg Syndrome:A Focal Form of Stiff-Man Syndrome
Ann Neurol 43:400-403, Saiz,A.,et al, 1998



Showing articles 650 to 700 of 1195 << Previous Next >>